Specify a stock or a cryptocurrency in the search bar to get a summary
EQL PHARMA AB
7JKEQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden. Address: Stortorget 1, Lund, Sweden, 222 23
Analytics
WallStreet Target Price
–P/E ratio
70.25Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 7JK
Dividend Analytics 7JK
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 7JK
Stock Valuation 7JK
Financials 7JK
Results | 2019 | Dynamics |